Skip to content

Clinical trials

Terminated Observational Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Status: Terminated Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20085
20094
20103
20132
20141
20163
20172
20182
20192
20204
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt-Ingram Cancer Center4
Celgene3
Adaptive Biotechnologies1
Assistance Publique - Hôpitaux de Paris1
Barbara Ann Karmanos Cancer Institute1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Cogent Biosciences, Inc.1
Columbia University1
CureOne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma37
Leukemia, Lymphocytic, Chronic, B-Cell12
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia, Myeloid, Acute10
Lymphoma10
Lymphoma, Non-Hodgkin10
Lymphoma, Follicular9
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Mantle-Cell9
Myelodysplastic Syndromes9

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.